commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection.
评估两种含四种口蹄疫病毒血清型抗原的商业疫苗在牛中的抗体反应,采样持续360天,用固相竞争ELISA和病毒中和试验检测。抗体反应因疫苗、剂量方案、血清型和检测方法差异很大,多数不足以确保高概率的充分或持续保护。一种疫苗两剂基础免疫优于其他方案,但仅对一种血清型的病毒中和试验数据提示75%犊牛可能保护6个月。
要点
- 抗体反应因疫苗、剂量方案、血清型和检测方法差异很大。
- 多数方案抗体水平不足以确保高概率的充分或持续保护。
- 一种疫苗两剂基础免疫仅对一种血清型提示6个月 probable protection。
核心结论
- 东非使用的口蹄疫疫苗免疫原性存在差距,强调独立质量控制研究对评估和改进商业口蹄疫疫苗及接种方案的重要性。
研究设计与样本
- 对37头犊牛接种两种含四种口蹄疫病毒血清型抗原的商业疫苗进行基础免疫,部分在28天后接种第二剂。
- 使用新生产批次疫苗在免疫后180天对所有犊牛加强接种,另10头 naïve 犊牛也使用新批次疫苗并随访约180天。
- 采样持续360天,用固相竞争ELISA和病毒中和试验检测各血清型抗体。
主要发现
- 抗体反应因疫苗、剂量方案、血清型和检测方法差异很大,但多数不足以确保高概率的充分或持续保护。
- 一种疫苗以两剂基础免疫接种优于其他选项,但即使如此,病毒中和试验数据轨迹提示仅对一种病毒血清型有75%犊牛可能保护6个月。
- 接种另一种疫苗的犊牛和仅接受单剂基础免疫的犊牛抗体水平低,预测可能保护持续不到两个月。
- 单个固相竞争ELISA结果与中和试验及保护可能性弱相关(r2=0.48),但两种方法对哪种疫苗和剂量方案表现最佳意见一致。
关键数值与推荐
- 病毒中和试验数据提示一种疫苗两剂基础免疫后75%犊牛可能保护6个月,仅对一种病毒血清型。
- 固相竞争ELISA结果与中和试验的相关系数 r2=0.48。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Foot-and-mouth disease virus (FMDV) causes a contagious disease (FMD) in cloven-hoofed animals. For FMD-endemic countries, vaccination is critical for controlling disease but is rarely monitored, despite substantial funds spent on vaccine purchases. We evaluated antibody responses in cattle to two commercial vaccines each containing antigens of four FMDV serotypes. Sampling was done over 360 days, with serology for each serotype performed using commercially available solid phase competition ELISAs (SPCE) and with virus neutralization tests (VNT) employing regionally relevant test viruses. A primary course of each vaccine was administered to 37 calves, some of which received a second dose after 28 days. Using new production batches of vaccines, all calves received a booster vaccination 180 days post vaccination, while 10 additional naïve calves were also vaccinated using the new batches and followed up for ∼180 days. Simple and general linear models were used to compare antibody responses which varied substantially according to vaccine, dose regime, serotype, and test, but were mostly insufficient to ensure a high likelihood of adequate or sustained probable protection. One of the vaccines administered as a two-dose primary course of vaccination was superior to other options, but even then, data trajectories from VNT responses suggested probable protection of 75 % of calves for 6 months for only one virus serotype. Calves administered with the other vaccine and those given a single primary dose developed low levels of antibodies, offering predicted likely protection lasting less than two months. Individual SPCE results were weakly correlated (r2 = 0.48) to neutralization and associated likelihoods of protection but SPCE and VNT agreed on which vaccine and dose regime performed best. Our findings highlight gaps in immunogenicity of FMD vaccines used in East Africa and reinforce the importance of independent quality control studies to evaluate and improve commercial FMD vaccines and vaccination regimes.
引用
- Kerfua SD, Haydon DT, Wilsden G, et al. Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection. Vaccine. 2024. PMID: 39270355. doi:10.1016/j.vaccine.2024.126325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。